|
Volumn , Issue 95, 2005, Pages 263-264
|
Intravenous magnesium sulfate to improve outcome after aneurysmal subarachnoid hemorrhage: Interim report from a pilot study
|
Author keywords
Intracranial aneurysm; magnesium kwrandomized controlled trial; subarachnoid haemorrhage (SAH); vasospasm
|
Indexed keywords
MAGNESIUM SULFATE;
VASODILATOR AGENT;
ARTICLE;
BRAIN VASOSPASM;
CLINICAL TRIAL;
COMORBIDITY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HONG KONG;
HUMAN;
INCIDENCE;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
OUTCOME ASSESSMENT;
PILOT STUDY;
PROGNOSIS;
RANDOMIZED CONTROLLED TRIAL;
RISK ASSESSMENT;
RISK FACTOR;
SUBARACHNOID HEMORRHAGE;
TREATMENT OUTCOME;
COMORBIDITY;
DOUBLE-BLIND METHOD;
FEMALE;
HONG KONG;
HUMANS;
INCIDENCE;
INFUSIONS, INTRAVENOUS;
MAGNESIUM SULFATE;
MALE;
MIDDLE AGED;
OUTCOME ASSESSMENT (HEALTH CARE);
PILOT PROJECTS;
PROGNOSIS;
RISK ASSESSMENT;
RISK FACTORS;
SUBARACHNOID HEMORRHAGE;
TREATMENT OUTCOME;
VASODILATOR AGENTS;
VASOSPASM, INTRACRANIAL;
|
EID: 33644848789
PISSN: 00651419
EISSN: None
Source Type: Book Series
DOI: 10.1007/3-211-32318-X_53 Document Type: Conference Paper |
Times cited : (20)
|
References (5)
|